Evidence map›Paper›PMID 25750901›Full record

ReviewResearch and reports in urology2015

Management of erectile dysfunction post-radical prostatectomy.

Alan Saleh, Hamid Abboudi, Mb Ghazal-Aswad, Erik K Mayer, Justin A Vale

Open access · goldAbstract readReview
In one paragraph

Review in Research and reports in urology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Post-Radical Prostatectomy Erectile Dysfunction Assessed Using the IIEF-5 Questionnaire - A Systematic Literature Review.International journal of sexual health : official journal of the World Association for Sexual Health · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alan SalehDivision of Surgery and Cancer, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.
Hamid AbboudiDivision of Surgery and Cancer, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.
Mb Ghazal-AswadDivision of Surgery and Cancer, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.
Erik K MayerDivision of Surgery and Cancer, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.
Justin A ValeDivision of Surgery and Cancer, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.
St Mary's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radical prostatectomy is a commonly performed procedure for the treatment of localized prostate cancer. One of the long-term complications is erectile dysfunction. There is little consensus on the optimal management; however, it is agreed that treatment must be prompt to prevent fibrosis and increase oxygenation of penile tissue. It is vital that patient expectations are discussed, a realistic time frame of treatment provided, and treatment started as close to the prostatectomy as possible. Current treatment regimens rely on phosphodiesterase 5 inhibitors as a first-line therapy, with vacuum erection devices and intraurethral suppositories of alprostadil as possible treatment combination options. With nonresponders to these therapies, intracavernosal injections are resorted to. As a final measure, patients undergo the highly invasive penile prosthesis implantation. There is no uniform, objective treatment program for erectile dysfunction post-radical prostatectomy. Management plans are based on poorly conducted and often underpowered studies in combination with physician and patient preferences. They involve the aforementioned drugs and treatment methods in different sequences and doses. Prospective treatments include dietary supplements and gene therapy, which have shown promise with there proposed mechanisms of improving erectile function but are yet to be applied successfully in human patients.

Indexed as

erectile dysfunctionintracavernosal injectionsintraurethral suppositoriesphosphodiesterase 5 inhibitorsvacuum erection devices

Identifiers

PMID25750901
PMCPMC4348059
OpenAlexW2028649685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.